Nicholas McGrath
Compliance Officer bei Golden Gate Private Equity, Inc.
Profil
Nicholas McGrath is the Chief Compliance Officer, Chief Regulatory Counsel, and Associate General Counsel of Golden Gate Capital.
Prior to joining Golden Gate Capital, Mr. McGrath served as the General Counsel and Chief Compliance Officer at RA Capital and MPM Capital, two healthcare and biotech investment advisers, where he was responsible for managing the legal, regulatory, and compliance functions at each firm.
Mr. McGrath holds a J.D.
from the University of Maine School of Law, an LL.M.
from St. John’s University School of Law, and a B.A.
in International Business from the University of Massachusetts, Amherst.
He is an attorney in good standing in Massachusetts, New York, and Maine.
Mr. McGrath is also a FINRA Certified Regulatory and Compliance Professional.
Aktive Positionen von Nicholas McGrath
| Unternehmen | Position | Beginn |
|---|---|---|
Golden Gate Private Equity, Inc.
 Golden Gate Private Equity, Inc. Investment ManagersFinance Golden Gate Private Equity, Inc. (Golden Gate Capital) is a private equity firm founded in 2000 by David C. Dominik and Jesse T. Rogers. The firm is headquartered in San Francisco, California. | Compliance Officer | 01.03.2022 |
Ehemalige bekannte Positionen von Nicholas McGrath
| Unternehmen | Position | Ende |
|---|---|---|
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Compliance Officer | 01.03.2022 |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | 02.09.2021 |
TriNetX, LLC
 TriNetX, LLC Medical/Nursing ServicesHealth Services TriNetX, Inc. provides an online data network for collaborative research. It enables hospitals, academic medical centers, physician networks, practices, and pharmaceuticals to participate in collaborative research and a public and private sustainability model for research informatics. The company was founded by Bard Geesaman in 2013 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 02.10.2020 |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Compliance Officer | 02.04.2018 |
Ausbildung von Nicholas McGrath
| St. John's University School of Law | Graduate Degree |
| University of Maine School of Law | Graduate Degree |
| University of Massachusetts Amherst | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Golden Gate Private Equity, Inc.
Golden Gate Private Equity, Inc. Investment ManagersFinance Golden Gate Private Equity, Inc. (Golden Gate Capital) is a private equity firm founded in 2000 by David C. Dominik and Jesse T. Rogers. The firm is headquartered in San Francisco, California. | Finance |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | Retail Trade |
TriNetX, LLC
TriNetX, LLC Medical/Nursing ServicesHealth Services TriNetX, Inc. provides an online data network for collaborative research. It enables hospitals, academic medical centers, physician networks, practices, and pharmaceuticals to participate in collaborative research and a public and private sustainability model for research informatics. The company was founded by Bard Geesaman in 2013 and is headquartered in Cambridge, MA. | Health Services |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Finance |
